• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液中的 Tau 蛋白:死亡时间的新型生物标志物?

Tau protein in cerebrospinal fluid: a novel biomarker of the time of death?

机构信息

Department of Forensic Medicine, CHU Montpellier, University of Montpellier, Montpellier, France.

IRMB, INM, University of Montpellier, INSERM, CHU Montpellier, (LBPC-PPC), Montpellier, France.

出版信息

Int J Legal Med. 2021 Sep;135(5):2081-2089. doi: 10.1007/s00414-021-02558-3. Epub 2021 Mar 19.

DOI:10.1007/s00414-021-02558-3
PMID:33740116
Abstract

BACKGROUND

Tau proteins are recognized biomarkers of neurodegeneration and neuronal damage in the cerebrospinal fluid (CSF). It has also been suggested that these CSF proteins could increase post-mortem due to neuronal death. The aim of this study was to investigate the changes in CSF total and phosphorylated tau (p-tau) levels in the early post-mortem interval (PMI), to determine whether these proteins could be relevant biomarkers of time since death.

METHODS

Tau and p-tau levels were measured by ELISA in lumbar and cisternal CSF samples from 82 corpses (46 men, 36 women, mean age: 72.4 ± 15.2 years) with a PMI < 12 h. Forty-eight of them were considered neurologically healthy at the time of death. Rectal and tympanic temperatures were also measured in 37 individuals, and two validated temperature-based methods of PMI estimation were applied (Henssge's nomogram and Baccino's method).

RESULTS

CSF tau and p-tau levels were significantly increased, with respective median values of 3315 pg/mL and 68.5 pg/mL in the whole cohort, while lower but still increased levels were observed in neurologically healthy patients. Sub-occipital punctures systematically provided higher tau and p-tau values (p < 0.0001). Despite a great inter-individual variability, the concentrations of both biomarkers were positively correlated with the early PMI, with the highest correlation for cisternal p-tau (r = 0.50, p < 0.0001 in the whole cohort; r = 0.58, p = 0.0003 in the neurologically healthy patients). Higher levels of CSF biomarkers were observed for PMI > 6 h versus PMI ≤ 6 h, the discriminatory power of the biomarkers being higher in the subgroup of neurologically healthy patients. Based on cut-off values obtained by ROC curve analysis, the CSF biomarkers could rectify or adjust the time interval provided by the temperature-based methods in a significant number of cases. A predictive model combining tympanic temperature and cisternal tau values was found to be particularly accurate to assign individuals according to their PMI (≤ or > 6 h), with a Se of 83% and a Sp of 100% (AUC = 0.95).

CONCLUSION

Our findings suggest that CSF tau and p-tau proteins could serve as potential biomarkers of time since death, in association with tympanic temperature. The practical applicability of such an integrated approach has to be assessed by further studies.

摘要

背景

tau 蛋白被认为是中枢神经系统(CSF)中神经退行性变和神经元损伤的生物标志物。也有人认为,这些 CSF 蛋白可能会因神经元死亡而在死后增加。本研究旨在探讨死后早期(PMI)CSF 总 tau(t-tau)和磷酸化 tau(p-tau)水平的变化,以确定这些蛋白是否可作为死亡时间的相关生物标志物。

方法

对 82 例尸检(46 名男性,36 名女性,平均年龄:72.4±15.2 岁)死后 PMI<12 小时的腰椎和脑池 CSF 样本进行 ELISA 检测。其中 48 例在死亡时被认为是神经健康的。还测量了 37 个人的直肠和鼓室温度,并应用了两种经过验证的 PMI 估计的基于温度的方法(Henssge 列线图和 Baccino 方法)。

结果

tau 和 p-tau 的 CSF 水平明显升高,整个队列的中位数分别为 3315pg/ml 和 68.5pg/ml,而神经健康患者的水平虽然较低,但仍有升高。枕下穿刺系统地提供了更高的 tau 和 p-tau 值(p<0.0001)。尽管个体间存在很大的变异性,但两种生物标志物的浓度与早期 PMI 呈正相关,脑池 p-tau 的相关性最高(整个队列中 r=0.50,p<0.0001;r=0.58,p=0.0003 在神经健康的患者中)。与 PMI≤6 小时相比,PMI>6 小时的 CSF 生物标志物水平更高,在神经健康患者的亚组中,生物标志物的判别能力更高。基于 ROC 曲线分析获得的截断值,CSF 生物标志物可以纠正或调整基于温度的方法提供的时间间隔,在大量病例中效果显著。发现结合鼓室温度和脑池 tau 值的预测模型对于根据 PMI(≤或>6 小时)分配个体特别准确,Se 为 83%,Sp 为 100%(AUC=0.95)。

结论

我们的研究结果表明,CSF tau 和 p-tau 蛋白可能与鼓室温度一起作为死亡时间的潜在生物标志物。这种综合方法的实际适用性需要进一步研究来评估。

相似文献

1
Tau protein in cerebrospinal fluid: a novel biomarker of the time of death?脑脊液中的 Tau 蛋白:死亡时间的新型生物标志物?
Int J Legal Med. 2021 Sep;135(5):2081-2089. doi: 10.1007/s00414-021-02558-3. Epub 2021 Mar 19.
2
Estimation of the time since death based on body cooling: a comparative study of four temperature-based methods.基于尸体冷却推断死亡时间的研究:四种基于温度推断方法的比较。
Int J Legal Med. 2021 Nov;135(6):2479-2487. doi: 10.1007/s00414-021-02635-7. Epub 2021 Jun 19.
3
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.特发性正常压力脑积水神经退行性生物标志物的脑脊液时间趋势。
J Alzheimers Dis. 2021;80(4):1629-1642. doi: 10.3233/JAD-201361.
4
Cerebrospinal fluid tau proteins in status epilepticus.癫痫持续状态下的脑脊液tau蛋白
Epilepsy Behav. 2015 Aug;49:150-4. doi: 10.1016/j.yebeh.2015.04.030. Epub 2015 May 6.
5
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.阿尔茨海默病脑脊液生物标志物在早期帕金森病中的演变。
Ann Neurol. 2020 Sep;88(3):574-587. doi: 10.1002/ana.25811. Epub 2020 Jul 2.
6
Small cisterno-lumbar gradient of phosphorylated Tau protein in geriatric patients with suspected normal pressure hydrocephalus.疑似正常压力脑积水老年患者中磷酸化 Tau 蛋白的小脑延髓池-腰椎梯度较小。
Fluids Barriers CNS. 2016 Aug 31;13(1):15. doi: 10.1186/s12987-016-0039-9.
7
Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.生前脑脊液tau水平与额颞叶变性中的死后tau病理学相关。
Ann Neurol. 2017 Aug;82(2):247-258. doi: 10.1002/ana.24996. Epub 2017 Aug 19.
8
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.脑脊液总tau蛋白浓度可预测亨廷顿舞蹈病的临床表型。
J Neurochem. 2016 Oct;139(1):22-5. doi: 10.1111/jnc.13719. Epub 2016 Sep 20.
9
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.阿尔茨海默病标准化脑脊液生物标志物在澳大利亚成像、生物标志物和生活方式(AIBL)研究中经PET淀粉样β蛋白特征化的受试者中得到验证。
J Alzheimers Dis. 2015;48(1):175-87. doi: 10.3233/JAD-150247.
10
Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer's Disease Spectrum with Amyloid PET Imaging.两种分析平台在脑脊液生物标志物用于阿尔茨海默病谱系与淀粉样蛋白PET成像分类中的比较
J Alzheimers Dis. 2020;75(3):949-958. doi: 10.3233/JAD-191331.

引用本文的文献

1
Comparative analysis of anticoagulant influence on PMI estimation based on porcine blood metabolomics profile measured using GC-MS.基于气相色谱-质谱联用仪测量的猪血代谢组学图谱对抗凝剂对死后间隔时间估计影响的比较分析。
Front Mol Biosci. 2025 Jan 7;11:1400622. doi: 10.3389/fmolb.2024.1400622. eCollection 2024.
2
The polychromatism of postmortem cerebrospinal fluid.死后脑脊液的多色性。
Forensic Sci Med Pathol. 2024 Aug 30. doi: 10.1007/s12024-024-00887-4.
3
An experimental study to estimate the early postmortem interval based on the degradation of lncRNAs in rat brain tissue.

本文引用的文献

1
Biochemical markers of time since death in cerebrospinal fluid: A first step towards .脑脊液中死亡时间的生化标志物:迈向……的第一步。
Crit Rev Clin Lab Sci. 2019 Jun;56(4):274-286. doi: 10.1080/10408363.2019.1619158. Epub 2019 Jun 6.
2
Restoration of brain circulation and cellular functions hours post-mortem.恢复死后数小时的大脑循环和细胞功能。
Nature. 2019 Apr;568(7752):336-343. doi: 10.1038/s41586-019-1099-1. Epub 2019 Apr 17.
3
Evaluation of postmortem biochemical markers: Completeness of data and assessment of implication in the field.
基于大鼠脑组织中长链非编码 RNA 降解估计早期死后间隔时间的实验研究。
Sci Rep. 2024 Aug 23;14(1):19586. doi: 10.1038/s41598-024-70678-y.
4
PMI estimation through metabolomics and potassium analysis on animal vitreous humour.通过代谢组学和动物玻璃体中钾分析进行 PMI 估计。
Int J Legal Med. 2023 May;137(3):887-895. doi: 10.1007/s00414-023-02975-6. Epub 2023 Feb 17.
5
TDP-43 CSF Concentrations Increase Exponentially with Age in Metropolitan Mexico City Young Urbanites Highly Exposed to PM and Ultrafine Particles and Historically Showing Alzheimer and Parkinson's Hallmarks. Brain TDP-43 Pathology in MMC Residents Is Associated with High Cisternal CSF TDP-43 Concentrations.在墨西哥城大都市中,高度暴露于细颗粒物(PM)和超细颗粒物且历史上呈现阿尔茨海默病和帕金森病特征的年轻城市居民中,TDP - 43脑脊液浓度随年龄呈指数增长。墨西哥城居民的脑TDP - 43病理学与高脑池脑脊液TDP - 43浓度相关。
Toxics. 2022 Sep 24;10(10):559. doi: 10.3390/toxics10100559.
6
Effect of Selenium Treatment on Central Insulin Sensitivity: A Proteomic Analysis in β-Amyloid Precursor Protein/Presenilin-1 Transgenic Mice.硒治疗对中枢胰岛素敏感性的影响:β-淀粉样前体蛋白/早老素-1转基因小鼠的蛋白质组学分析
Front Mol Neurosci. 2022 Jul 7;15:931788. doi: 10.3389/fnmol.2022.931788. eCollection 2022.
7
Systematic Review on Post-Mortem Protein Alterations: Analysis of Experimental Models and Evaluation of Potential Biomarkers of Time of Death.死后蛋白质变化的系统评价:实验模型分析及死亡时间潜在生物标志物的评估
Diagnostics (Basel). 2022 Jun 17;12(6):1490. doi: 10.3390/diagnostics12061490.
死后生化标志物评估:数据完整性及该领域意义评估
Sci Justice. 2019 Mar;59(2):177-180. doi: 10.1016/j.scijus.2018.09.002. Epub 2018 Sep 7.
4
Terminal spreading depolarization and electrical silence in death of human cerebral cortex.人类大脑皮层死亡时的终末扩散性去极化和电沉默。
Ann Neurol. 2018 Feb;83(2):295-310. doi: 10.1002/ana.25147. Epub 2018 Feb 15.
5
Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke.急性缺血性中风患者脑脊液和血浆中的神经颗粒蛋白和tau蛋白
BMC Neurol. 2017 Aug 30;17(1):170. doi: 10.1186/s12883-017-0945-8.
6
Methods for determining time of death.确定死亡时间的方法。
Forensic Sci Med Pathol. 2016 Dec;12(4):451-485. doi: 10.1007/s12024-016-9776-y. Epub 2016 Jun 4.
7
Defeating Alzheimer's disease and other dementias: a priority for European science and society.战胜阿尔茨海默病及其他痴呆症:欧洲科学与社会的当务之急。
Lancet Neurol. 2016 Apr;15(5):455-532. doi: 10.1016/S1474-4422(16)00062-4.
8
Tau in physiology and pathology.tau 在生理学和病理学中的作用。
Nat Rev Neurosci. 2016 Jan;17(1):5-21. doi: 10.1038/nrn.2015.1. Epub 2015 Dec 3.
9
Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study.2008-2012 年法国阿尔茨海默病计划对研究记忆中心脑脊液生物标志物使用的影响:PLM 研究。
J Alzheimers Dis. 2013;34(1):297-305. doi: 10.3233/JAD-121549.
10
Postmortem chemistry update part II.死后化学更新第二部分。
Int J Legal Med. 2012 Mar;126(2):199-215. doi: 10.1007/s00414-011-0614-1. Epub 2011 Oct 9.